Douglas Lane & Associates’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-11,000
| Closed | -$8.72K | – | 242 |
|
|
2023
Q4 | $8.72K | Hold |
11,000
| – | – | ﹤0.01% | 245 |
|
|
2023
Q3 | $8.58K | Sell |
11,000
-2,000
| -15% | -$1.56K | ﹤0.01% | 234 |
|
|
2023
Q2 | $12K | Hold |
13,000
| – | – | ﹤0.01% | 233 |
|
|
2023
Q1 | $14.2K | Hold |
13,000
| – | – | ﹤0.01% | 227 |
|
|
2022
Q4 | $19K | Buy |
+13,000
| New | +$19K | ﹤0.01% | 226 |
|